| Real-life clinical data of lenvatinib versus sorafenib for unresectable hepatocellular carcinoma in Italy V Burgio, M Iavarone, GG Di Costanzo, F Marra, S Lonardi, E Tamburini, ... Cancer Management and Research, 9379-9389, 2021 | 35 | 2021 |
| Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence C Celsa, C Stornello, P Giuffrida, CM Giacchetto, M Grova, G Rancatore, ... Annals of Hepatology 27, 100568, 2022 | 15 | 2022 |
| Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors B Stefanini, L Bucci, V Santi, N Reggidori, D Rampoldi, L Lani, A Granito, ... Digestive and Liver Disease 54 (11), 1563-1572, 2022 | 13 | 2022 |
| Role of etiology in hepatocellular carcinoma patients treated with Lenvatinib: a counterfactual event-based mediation analysis R Sacco, D Ramai, R Tortora, GG di Costanzo, ME Burlone, M Pirisi, ... Cancers 15 (2), 381, 2023 | 8 | 2023 |
| Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis C Celsa, G Cabibbo, DJ Pinato, G Di Maria, M Enea, M Vaccaro, ... Liver Cancer 13 (2), 169, 2024 | 6 | 2024 |
| Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection F Pelizzaro, F Trevisani, V Simeon, A Vitale, U Cillo, F Piscaglia, ... Liver International 43 (12), 2762-2775, 2023 | 6 | 2023 |
| Hepatotoxicity of systemic therapies for unresectable hepatocellular carcinoma C Celsa, P Giuffrida, CM Giacchetto, C Stornello, G Rancatore, M Grova, ... Liver Cancer International 2 (3), 82-95, 2021 | 5 | 2021 |
| Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs N Reggidori, L Bucci, V Santi, B Stefanini, L Lani, D Rampoldi, G Ghittoni, ... JHEP Reports 5 (8), 100784, 2023 | 4 | 2023 |
| The evolving scenario in the assessment of radiological response for hepatocellular carcinoma in the era of immunotherapy: strengths and weaknesses of surrogate endpoints P Giuffrida, C Celsa, M Antonucci, M Peri, MV Grassini, G Rancatore, ... Biomedicines 10 (11), 2827, 2022 | 4 | 2022 |
| Efficacy and safety of Atezolizumab plus Bevacizumab-based sequential treatment for unresectable hepatocellular carcinoma: A simulation model C Celsa, G Cabibbo, S Battaglia, P Giuffrida, GEM Rizzo, M Grova, ... Journal of Hepatology 77, S387-S388, 2022 | 4 | 2022 |
| Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma EG Giannini, G Pieri, S Labanca, MCP Torres, A Gasbarrini, E Biasini, ... Digestive and Liver Disease 54 (9), 1215-1221, 2022 | 3 | 2022 |
| Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma EG Giannini, A Pasta, G Pieri, MC Plaz Torres, M Marseglia, F Pelizzaro, ... Liver International, 2024 | 1 | 2024 |
| The burden of HDV infection: A ten-years’ experience of a sicilian tertiary centre of liver disease GEM Rizzo, D Ferraro, G Rancatore, P Graceffa, G Falco, C La Mantia, ... Digestive and Liver Disease 55, S59, 2023 | 1 | 2023 |
| Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma A Vitale, P Romano, U Cillo, M Busti, G Nezi, R De Carlis, F Ratti, ... JAMA surgery, 0 | 1 | |
| Navigating the Labyrinth: When the “Mesenterium Commune” Turns Colonoscopy into an Endoscopic Rollercoaster GEM Rizzo, S Ferriolo, L Carrozza, G Rancatore, M Traina Diagnostics 14 (11), 1072, 2024 | | 2024 |
| Multidisciplinary management of a rare case of obstructive jaundice GEM Rizzo, L Carrozza, S Gruttadauria, A Bertani, D Ligresti, ... Endoscopy 56 (S 02), eP428V, 2024 | | 2024 |
| A systematic review and meta-analysis of diagnostic outcomes of endoscopic ultrasound guided liver biopsy versus percutaneous liver biopsy G Rancatore, GEM Rizzo, M Traina, L Carrozza, C Celsa, D Ligresti, ... Endoscopy 56 (S 02), MP032, 2024 | | 2024 |
| Endoscopic ultrasound guided biopsy of focal liver lesions: a tertiary care single center experience G Rancatore, D Ligresti, GEM Rizzo, L Carrozza, M Traina, I Tarantino Endoscopy 56 (S 02), MP034, 2024 | | 2024 |
| Trans-oesophageal biopsy for lung masses: a prospective analysis of performances of EUS-guided FNB in a tertiary center GEM Rizzo, M Traina, D Ligresti, L Carrozza, G Rancatore, A Bertani, ... Endoscopy 56 (S 02), MP039, 2024 | | 2024 |
| Optimal removal time of lumen-apposing metal stent (LAMS) after placement for drainage of pancreatic fluid collections: a systematic review and meta-analysis M Maida, GEM Rizzo, L Carrozza, G Rancatore, D Ligresti, M Traina, ... Endoscopy 56 (S 02), MP275, 2024 | | 2024 |
